5,6,7,8-tetrahydro-4H-furo[3,2-c]azepin-4-one, 95.0%, 250mg

2,2,2-Trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethanone, 97%, 5g

Dbco-Amine TFA, 95.0%, 50mg

2-(3-Cyanophenylmethoxy)phenylboronic acid, 95+%, 100mg

1-(Naphthalen-1-yl)urea, 95+%, 1g

4-Fluoro-3-methylphenylboronic Acid (contains varying amounts of Anhydride)5g

1-(5-BROMO-1H-PYRROL-2-YL)ETHAN-1-ONE, 95%, 5g

3-(Difluoromethyl)-1-methyl-5-(3-(trifluoromethyl)phenoxy)-1H-pyrazole-4-carboxylic acid, 98%, 250mg

n-Alkan standard solution (C7,C8,C9,C10-C40), 19 components (each 50 mg/l) in isooctane

1-Bromo-2-(dimethoxymethyl)benzene, 97%, 25g

Sodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate xhydrate, 95.0%, 5g

Magnesium acetate tetrahydrate, min. 98%, pa, ACS, 500 g, plastic packaging.

2-(3-Methoxyphenoxy)ethanimidamide hydrochloride, 95.0%, 1g